Viewing Study NCT01714193


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-01-01 @ 8:02 AM
Study NCT ID: NCT01714193
Status: COMPLETED
Last Update Posted: 2012-11-19
First Post: 2012-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR014755
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators